Fiduciary Financial Group’s ResMed RMD Stock Holding History

Fiduciary Financial Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,165	Closed	-$272K	–	315
2024 Q4	$272K	Buy	1,165 +40	+4%	+$9.63K	0.06%	223
2024 Q3	$266K	Buy	+1,125	New	+$251K	0.06%	226

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Fiduciary Financial Group's RMD Position: Q1 2025 in Review

Fiduciary Financial Group sold out of ResMed (RMD) in Q1 2025, closing a stake of 1,165 shares — an estimated $272K sold.

Fiduciary Financial Group first reported a position in RMD in Q3 2024 and held it in 2 quarters. The position peaked at $272K in Q4 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

Fiduciary Financial Group reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
Fiduciary Financial Group sold 1,165 ResMed shares in Q1 2025, an estimated $272K.
Fiduciary Financial Group first reported a position in ResMed in Q3 2024 and held it in 2 quarters.
Fiduciary Financial Group's ResMed position peaked at $272K in Q4 2024.
885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Fiduciary Financial Group's 13F filing for Q1 2025, filed 15 Apr 2025.